164 related articles for article (PubMed ID: 29242635)
1. MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV gene.
Qin SC; Xia Y; Miao Y; Zhu HY; Wu JZ; Fan L; Li JY; Xu W; Qiao C
Blood Cancer J; 2017 Dec; 7(12):651. PubMed ID: 29242635
[No Abstract] [Full Text] [Related]
2. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
[TBL] [Abstract][Full Text] [Related]
3. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.
Shi K; Sun Q; Qiao C; Zhu H; Wang L; Wu J; Wang L; Fu J; Young KH; Fan L; Xia Y; Xu W; Li J
Cancer Med; 2020 Feb; 9(3):999-1007. PubMed ID: 31849198
[TBL] [Abstract][Full Text] [Related]
4. Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
Lech-Maranda E; Grzybowska-Izydorczyk O; Wyka K; Mlynarski W; Borowiec M; Antosik K; Cebula-Obrzut B; Makuch-Lasica H; Nowak G; Klimkiewicz-Wojciechowska G; Wawrzyniak E; Bilinski P; Robak T; Warzocha K
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):477-86. PubMed ID: 22945689
[TBL] [Abstract][Full Text] [Related]
5. Another step forward in the 20-year history of
Giudice ID; Foà R
Haematologica; 2019 Feb; 104(2):219-221. PubMed ID: 30705114
[No Abstract] [Full Text] [Related]
6. Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.
Stamatopoulos B; Timbs A; Bruce D; Smith T; Clifford R; Robbe P; Burns A; Vavoulis DV; Lopez L; Antoniou P; Mason J; Dreau H; Schuh A
Leukemia; 2017 Apr; 31(4):837-845. PubMed ID: 27795555
[TBL] [Abstract][Full Text] [Related]
7. Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia.
Rodríguez CM; Stanganelli C; Bussi C; Arroyo D; Sastre D; Heller V; Iribarren P; Slavutsky I
Leuk Lymphoma; 2018 May; 59(5):1239-1243. PubMed ID: 28868956
[No Abstract] [Full Text] [Related]
8. Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.
Delgado J; Salaverria I; Baumann T; Martínez-Trillos A; Lee E; Jiménez L; Navarro A; Royo C; Santacruz R; López C; Payer AR; Colado E; González M; Armengol L; Colomer D; Pinyol M; Villamor N; Aymerich M; Carrió A; Costa D; Clot G; Giné E; López-Guillermo A; Campo E; Beà S
Haematologica; 2014 Nov; 99(11):e231-4. PubMed ID: 24997154
[No Abstract] [Full Text] [Related]
9. CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.
Gonzalez D; Else M; Wren D; Usai M; Buhl AM; Parker A; Oscier D; Morgan G; Catovsky D
Haematologica; 2013 Feb; 98(2):274-8. PubMed ID: 22899580
[TBL] [Abstract][Full Text] [Related]
10. Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia.
Visco C; Moretta F; Falisi E; Facco M; Maura F; Novella E; Nichele I; Finotto S; Giaretta I; Ave E; Perbellini O; Guercini N; Scupoli MT; Trentin L; Trimarco V; Neri A; Semenzato G; Rodeghiero F; Pizzolo G; Ambrosetti A
Am J Hematol; 2013 Apr; 88(4):277-82. PubMed ID: 23450508
[TBL] [Abstract][Full Text] [Related]
11. Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?
Bomben R; Dal Bo M; Zucchetto A; Zaina E; Nanni P; Sonego P; Del Poeta G; Degan M; Gattei V
Leukemia; 2005 Aug; 19(8):1490-2. PubMed ID: 15944717
[No Abstract] [Full Text] [Related]
12. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
13. Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status.
Sheikholeslami MR; Ma W; Uyeji J; Tornyos K; Cone L; Mamus S; Albitar M
Br J Haematol; 2007 Nov; 139(3):507-9. PubMed ID: 17868045
[No Abstract] [Full Text] [Related]
14. UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?
Bhoi S; Baliakas P; Cortese D; Mattsson M; Engvall M; Smedby KE; Juliusson G; Sutton LA; Mansouri L
Haematologica; 2016 Feb; 101(2):e63-5. PubMed ID: 26589911
[No Abstract] [Full Text] [Related]
15. AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations.
Leuenberger M; Frigerio S; Wild PJ; Noetzli F; Korol D; Zimmermann DR; Gengler C; Probst-Hensch NM; Moch H; Tinguely M
Mod Pathol; 2010 Feb; 23(2):177-86. PubMed ID: 19898425
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.
Visco C; Maura F; Tuana G; Agnelli L; Lionetti M; Fabris S; Novella E; Giaretta I; Reda G; Barcellini W; Baldini L; Neri A; Rodeghiero F; Cortelezzi A
Clin Cancer Res; 2012 Apr; 18(7):1870-8. PubMed ID: 22322667
[TBL] [Abstract][Full Text] [Related]
17. Expression of
Plešingerová H; Janovská P; Mishra A; Smyčková L; Poppová L; Libra A; Plevová K; Ovesná P; Radová L; Doubek M; Pavlová Š; Pospíšilová Š; Bryja V
Haematologica; 2018 Feb; 103(2):313-324. PubMed ID: 29122990
[TBL] [Abstract][Full Text] [Related]
18. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
[TBL] [Abstract][Full Text] [Related]
19. Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia.
Huet S; Bouvard A; Ferrant E; Mosnier I; Chabane K; Salles G; Michallet AS; Hayette S; Sujobert P
Leukemia; 2020 Aug; 34(8):2257-2259. PubMed ID: 31996767
[No Abstract] [Full Text] [Related]
20. High CXCR3 on Leukemic Cells Distinguishes
Manukyan G; Papajik T; Mikulkova Z; Urbanova R; Kraiczova VS; Savara J; Kudelka M; Turcsanyi P; Kriegova E
J Immunol Res; 2020; 2020():7084268. PubMed ID: 32802894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
